Malbouisson Luiz Marcelo Sá, Silva João Manoel, Carmona Maria José Carvalho, Lopes Marcel Rezende, Assunção Murilo Santucci, Valiatti Jorge Luís Dos Santos, Simões Claudia Marques, Auler José Otavio Costa
Divisão de Anestesia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Av. Enéas Carvalho de Aguiar, 255 2° andar, Cerqueira César, 05403-900, São Paulo, SP, Brazil.
Hospital São Paulo - São Paulo Federal University, São Paulo, SP, Brazil.
BMC Anesthesiol. 2017 May 30;17(1):70. doi: 10.1186/s12871-017-0356-9.
Intraoperative fluid therapy guided by mechanical ventilation-induced pulse-pressure variation (PPV) may improve outcomes after major surgery. We tested this hypothesis in a multi-center study.
The patients were included in two periods: a first control period (control group; n = 147) in which intraoperative fluids were given according to clinical judgment. After a training period, intraoperative fluid management was titrated to maintain PPV < 10% in 109 surgical patients (PPV group). We performed 1:1 propensity score matching to ensure the groups were comparable with regard to age, weight, duration of surgery, and type of operation. The primary endpoint was postoperative hospital length of stay.
After matching, 84 patients remained in each group. Baseline characteristics, surgical procedure duration and physiological parameters evaluated at the start of surgery were similar between the groups. The volume of crystalloids (4500 mL [3200-6500 mL] versus 5000 mL [3750-8862 mL]; P = 0.01), the number of blood units infused during the surgery (1.7 U [0.9-2.0 U] versus 2.0 U [1.7-2.6 U]; P = 0.01), the fraction of patients transfused (13.1% versus 32.1%; P = 0.003) and the number of patients receiving mechanical ventilation at 24 h (3.2% versus 9.7%; P = 0.027) were smaller postoperatively in PPV group. Intraoperative PPV-based improved the composite outcome of postoperative complications OR 0.59 [95% CI 0.35-0.99] and reduced the postoperative hospital length of stay (8 days [6-14 days] versus 11 days [7-18 days]; P = 0.01).
In high-risk surgeries, PPV-directed volume loading improved postoperative outcomes and decreased the postoperative hospital length of stay.
ClinicalTrials.gov Identifier; retrospectively registered- NCT03128190.
在机械通气诱导的脉压变异(PPV)指导下进行术中液体治疗可能会改善大手术后的结局。我们在一项多中心研究中验证了这一假设。
患者分为两个阶段:第一个为对照阶段(对照组;n = 147),术中液体根据临床判断给予。经过一个培训期后,对109例手术患者(PPV组)进行术中液体管理滴定,以维持PPV < 10%。我们进行了1:1倾向评分匹配,以确保两组在年龄、体重、手术持续时间和手术类型方面具有可比性。主要终点是术后住院时间。
匹配后,每组各有84例患者。两组在手术开始时评估的基线特征、手术持续时间和生理参数相似。PPV组术后晶体液量(4500 mL [3200 - 6500 mL] 对 5000 mL [3750 - 8862 mL];P = 0.01)、手术期间输注的血制品单位数(1.7 U [0.9 - 2.0 U] 对 2.0 U [1.7 - 2.6 U];P = 0.01)、输血患者比例(13.1% 对 32.1%;P = 0.003)以及术后24小时接受机械通气的患者数(3.2% 对 9.7%;P = 0.027)均较少。基于术中PPV的治疗改善了术后并发症的综合结局,OR为0.59 [95% CI 0.35 - 0.99],并缩短了术后住院时间(8天 [6 - 14天] 对11天 [7 - 18天];P = 0.01)。
在高危手术中,PPV指导的容量负荷改善了术后结局并缩短了术后住院时间。
ClinicalTrials.gov标识符;回顾性注册 - NCT03128190。